In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization. by Vandeputte, P. et al.
In Vivo Systematic Analysis of Candida albicans Zn2-Cys6
Transcription Factors Mutants for Mice Organ
Colonization
Patrick Vandeputte, Franc¸oise Ischer, Dominique Sanglard, Alix T. Coste*
Institute of Microbiology, University of Lausanne and University Hospital Center, Lausanne, Switzerland
Abstract
The incidence of fungal infections in immuno-compromised patients increased considerably over the last 30 years. New
treatments are therefore needed against pathogenic fungi. With Candida albicans as a model, study of host-fungal
pathogen interactions might reveal new sources of therapies. Transcription factors (TF) are of interest since they integrate
signals from the host environment and participate in an adapted microbial response. TFs of the Zn2-Cys6 class are specific
to fungi and are important regulators of fungal metabolism. This work analyzed the importance of the C. albicans Zn2-Cys6
TF for mice kidney colonization. For this purpose, 77 Zn2-Cys6 TF mutants were screened in a systemic mice model of
infection by pools of 10 mutants. We developed a simple barcoding strategy to specifically detect each mutant DNA from
mice kidney by quantitative PCR. Among the 77 TF mutant strains tested, eight showed a decreased colonization including
mutants for orf19.3405, orf19.255, orf19.5133, RGT1, UGA3, orf19.6182, SEF1 and orf19.2646, and four an increased
colonization including mutants for orf19.4166, ZFU2, orf19.1685 and UPC2 as compared to the isogenic wild type strain. Our
approach was validated by comparable results obtained with the same animal model using a single mutant and the
revertant for an ORF (orf19.2646) with still unknown functions. In an attempt to identify putative involvement of such TFs in
already known C. albicans virulence mechanisms, we determined their in vitro susceptibility to pH, heat and oxidative
stresses, as well as ability to produce hyphae and invade agar. A poor correlation was found between in vitro and in vivo
assays, thus suggesting that TFs needed for mice kidney colonization may involve still unknown mechanisms. This large-
scale analysis of mice organ colonization by C. albicans can now be extended to other mutant libraries since our in vivo
screening strategy can be adapted to any preexisting mutants.
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Introduction
Candida albicans is an ubiquitous dimorphic organism colonizing
skin and mucosa of immuno-competent people without causing
any pathologies. In contrast, it is the cause of a wide spectrum of
diseases in immuno-compromized patients, ranging from benign
mucosal infections such as oral thrush to disseminated candidiasis,
which can be fatal. Oral and vaginal infections with C. albicans are
extremely common even in weakly immuno-compromized indi-
viduals. In severe cases of immunodeficiency, C. albicans penetrates
into deeper tissues and may enter the bloodstream. From the
bloodstream, the fungus has the potential to invade almost all body
sites and organs. Therefore, C. albicans is able to survive in radically
different environments with dramatic changes in physico-chemical
conditions such as oxygen and carbon dioxide tension, pH and
temperature. In addition, it has to escape host immune defenses,
even if they are weakened in immuno-compromized patients [1,2].
The therapy of C. albicans infections necessitates the use of
antifungal agents acting essentially against ergosterol, DNA and
cell wall biosynthesis as described in details in several reviews
[3,4,5,6]. The exposure of fungal pathogens to antifungal agents
can engage mechanisms enabling their adaptation and finally
resulting in drug resistance that is associated with treatment
failure. C. albicans resistance to antifungal agents is often the result
of genetic alterations such as gain-of-function mutations or
chromosomal rearrangements (for review see [7]), or of the
formation of multicellular associations known as biofilms [8,9]. In
the case of C. albicans systemic infections, treatment failures are
relatively frequent even in absence of in vitro measurable antifungal
resistance in specific fungal strains, leading to a mortality rate of
up to 30%. Therefore, it seems unlikely that existing antifungal
agents will have an impact on the mortality rate of systemic fungal
infections. A better understanding of host-pathogen interactions is
necessary to develop either new drugs and/or new clinical
approaches. These new therapeutic approaches may be combined
with existing antifungal chemotherapies and immunotherapies
[10].
Several studies have addressed this question in the past but
focusing only on the host immune response involving chemokines,
cytokines and effector cells [11,12,13,14]. These studies often
included analyses on a restricted number of genes or explored
transcriptome analysis essentially by ex vivo experiments
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[15,16,17,18,19,20] and one by in vivo analysis [21]. All these
analyses yielded a limited perspective on the interactions between
C. albicans and its host during the infectious process. Large scale
reverse genetic analyses of C. albicans genes involved in
environmental adaptation have been performed in vitro [22], and
thus are not appropriate for the study on host-pathogen
interactions. Very recently two studies performed in vivo large
scale analyses of C. albicans genes involved in the infectious process
[23,24]. Nevertheless these analyses did not focus on a specific
class of genes and were not exhaustive [23] or investigated
heterozygous mutants of essential genes but in which the effect of
the deletion of only one gene copy could not be visible [22]. Their
implementation was time- and cost-consuming and could not be
adapted to a pre-existing C. albicans mutant library.
In this study we propose a simple way to screen directly for host
colonization a collection of C. albicans Zn2-Cys6 transcription
factor (TF) mutants in a murine disseminated infection model. TFs
integrate several signals originating from the environment and
mediate adapted responses by modulating gene transcription.
Blocking a TF involved in the response to a specific host condition
may disarm the adapted fungus response that otherwise allows its
survival. Previous contributions confirm this hypothesis and
demonstrate that in C. albicans, deletion of genes encoding for
TFs result in significant decrease of virulence. These TFs are
involved in (i) adaptation to oxidative stress (CAP1 and RIM101)
[25,26,27,28], (ii) nitrogen regulation (GAT1), and (iii) yeast to
hyphae transition (CPH1, EFG1, TUP1, and CaNDT80)
[10,29,30,31,32,33]. Thus, TFs represent interesting candidates
to study virulence in order to design new antifungal strategies.
Among existing C. albicans TFs, the Zn2-Cys6 ‘‘zinc cluster’’
subclass is of particular interest since it is fungal-specific. In order
to address the involvement of TF of this family in host
colonization, we developed a system in which C. albicans TF
mutants are analysed in pools of 10 tagged strains. After C. albicans
DNA extraction from mice organs, quantitative PCR (qPCR) is
performed on specific tags and thus allows the relative quantifi-
cation of individual mutant in the population in infected tissues.
We tested 77 mutants of specific Zn2-Cys6 TF for their potential
in colonizing mice kidneys in a mouse model of systemic infection.
We were able to distinguish 8 and 4 mutants with reduced and
increased colonization, respectively, as compared to an isogenic
wild type strain. In an attempt to identify the putative function of
these TFs and to better elucidate their involvement in virulence
and/or colonization, we determined in vitro susceptibilities to heat,
pH and oxidative stresses as well as hyphae formation and agar
invasion of these 77 strains. These phenotypic tests revealed an
overall poor correlation with in vivo results, suggesting that most of
these TFs may regulate the expression of yet unidentified virulence
factors.
Materials and Methods
Strains and media
The C. albicans strains used in this study are listed in
Supplementary File S1. These mutants are part of a larger
collection of transcription factor mutants available at the Fungal
Genetic Stock Center (http://www.fgsc.net/). They were selected
for the presence of a fungal Zn2-Cys6 binuclear cluster DNA-
binding domain (Pfam accession number PF00172, http://pfam.
sanger.ac.uk/family/PF00172). The mutants were constructed by
four different gene inactivation strategies (see Supplementary File
S1), using two different parent strains, CAF4-2 [34] and BWP17
[35], which were both used as control strains throughout this
study. Each TF mutant was transformed with a plasmid containing
a barcode and was then renamed BCYi for ‘‘BarCoded Yeast’’
number i (see Table 1 and Supplementary file S1). Isolates were
grown in complete medium YEPD (1% Bacto peptone, Difco
Laboratories, Basel, Switzerland), 0.5% Yeast extract (Difco) and
2% glucose (Fluka, Buchs, Switzerland) or in minimal medium
YNB (Yeast Nitrogen Base) (Difco) and 2% glucose (Fluka). When
grown on solid media, 2% agar (Difco) was added. Escherichia coli
DH5a was used as a host for plasmid constructions and
propagation. DH5a was grown in LB (Luria-Bertani broth) or
LB plates, supplemented with ampicillin (0.1 mg/ml) when
required.
Yeast transformation
Yeast transformation was performed as described previously
[36].
Phenotypic tests
Eight different in vitro phenotypes, putatively relevant for
virulence and/or colonization in the host, were assessed for each
of our mutants by comparison with their wild type parental strains.
These phenotypic tests were performed by serial dilutions of fungal
cultures onto solid agar YEPD-based plates. Yeast cultures were
grown overnight in liquid YEPD and diluted to a density of
1.56105 cells/ml. Two serial 10-fold dilutions were performed to a
final dilution containing 1.56103 cells/ml. Four microliters of
each dilution were spotted onto YEPD-based plates and incubated
for 24 to 72 h depending on the condition tested. Following this
large scale screening, a refined screen was performed for mutants
with a phenotype differing from the wild type. For that purpose,
the same conditions were used except that six serially 5-fold
dilutions were spotted on agar plates. First, heat susceptibility was
tested by incubation at 42uC as compared to 35uC which
corresponds to the reference condition. We also determined the
susceptibility of our mutants to alkaline pH (pH 8.3 was achieved
by adding 50 mM of HEPES pH 8.5 and 25 mM NaOH) or
acidic pH (pH 3.35 was achieved by adding 50 mM of HEPES
pH 1.9). Third, we assessed the susceptibility to 1 mM and 5 mM
H2O2. Lastly, filamentation phenotype was determined by, either
plating each mutant onto YEPD agar plates supplemented with
10% of fetal calf serum (FCS), growing cells in 10% FCS liquid
YEPD medium for 4 h, and determining agar invasion capacity
after 48 h of growth in YEPD agar plates. All plates were recorded
for phenotypes after 24 and 48 h of incubation except for FCS-
supplemented plates, which were analyzed after 72 h of incuba-
tion. For cells grown in liquid medium, pictures were taken using
an Axiovert200 Zeiss inverted microscope with a 2006magnifi-
cation. This screening was repeated twice from independent
overnight cultures to assess the reproducibility of the results.
Construction of plasmids
Tagged-plasmids were constructed from CIp30 [37] and were
carrying STM tags consisting in random 40-nucleotides sequences
used in C. neoformans [38,39]. We chose 10 distinct STM tags with
numbers 6, 11, 20, 43, 209, 219, 224, 227, 232 and 240 (see
Table 2 for nucleotide sequences). First, complementary oligomers
(Table 2) containing the 40-mer sequence of the STM tag flanked
by the cohesive ends with NotI and DraIII restriction sites were
hybridized and digested by DraIII and NotI. Then, the double-
stranded oligomers were cloned into pKS(+) (Stratagene) at DraIII
and NotI sites and re-cloned into CIp30 at ScaI and NotI sites.
This cloning step was necessary since we discovered after sequence
analysis of CIp30 near the NotI site that the published CIp30 map
was not designed from a pKS(+) backbone but from a pKS(2)
backbone. Therefore we had to subclone the double-stranded
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Table 2. Sequences of oligonucleotides used in this study.
Primer name Sequence
Primers for STM tag
STM6-F gtgccatagctaccacacgatagctccccctagccccctacacgc
STM6-R ggccgcgtgtagggggctagggggagctatcgtgtggtagctatggcacgta
STM11-F gtgcacacgaaataaacctctaaacctcccccacaccaccccggc
STM11-R ggccgccggggtggtgtgggggaggtttagaggtttatttcgtgtgcacgta
STM20-F gtgatcaacaactaccgaccacgatcgacatccaacgccccatgc
STM20-R ggccgcatggggcgttggatgtcgatcgtggtcggtagttgttgatcacgta
STM43-F gtgccataaaaaaactagacccagctaccaatcacgctaccatgc
STM43-R ggccgcatggtagcgtgattggtagctgggtctagtttttttatggcacgta
STM209-F gtgctatcactctagcaatagcacaatctcgctctacccataagc
STM209-R ggccgcttatgggtagagcgagattgtgctattgctagagtgatagcacgta
STM219-F gtgccctaaaaccctacagcaatcacgatataccgctcccgacgc
STM219-R ggccgcgtcgggagcggtatatcgtgattgctgtagggttttagggcacgta
STM224-F gtgggtggtttgtgtgggtagagcgggggattgggggttaggggc
STM224-R ggccgcccctaacccccaatcccccgctctacccacacaaaccacccacgta
STM227-F gtgtggtcgcgggagatcgtggtttagagggagcgcggtctatgc
STM227-R ggccgcatagaccgcgctccctctaaaccacgatctcccgcgaccacacgta
STM232-F gtgatggcgttgtcgatatggttaggtagcgaggtcggttgcggc
STM232-R ggccgccgcaaccgacctcgctacctaaccatatcgacaacgccatcacgta
STM240-F gtgggcgctcgatcgcgggtgggtgttggatcggggtggatgggc
STM240-R ggccgcccatccaccccgatccaacacccacccgcgatcgagcgcccacgta
Primers for qPCR detection
Forward-primer ccgtctatcagggcgatg
Primer-STM6-rev cgcgtgtagggggcta
Primer-STM11-rev cgccggggtggtgt
Primer-STM20-rev catggggcgttggatg
Primer-STM43-rev gccgcggccgcatggtagcg
Primer-STM209-rev cggccgcttatgggta
Primer-STM219-rev cggccgcgtcgggagcggta
Primer-STM224-rev gcccctaacccccaatc
Primer-STM227-rev cgcggccgcatagac
Primer-STM232-rev gccgcaaccgacctc
Primer-STM240-rev tcgggatctaggcttgg
Primer-STM240-for tacgtgggcgctcgat
Probes for qPCR detection
probeLNA-STM6* [6FAM]tac+Cac+Acg+Ata+Gctcc[TAM]
probeDNA-STM11 [6FAM]CACACGAAATAAACCTCTAAACCTCCC[TAM]
probeLNA-STM20* [6FAM]caa+Caa+Cta+Ccg+Accacga[TAM]
probeLNA-STM43* [6FAM]aa+Cta+Gac+Cca+Gctacc[TAM]
probeDNA-STM209 [6FAM]ATCACTCTAGCAATAGCACAATCTCGC[TAM]
probeLNA-STM219* [6FAM]ccc+Tac+Agc+Aat+Cacga[TAM]
probeDNA-STM224 [6FAM]GGTGGTTTGTGTGGGTAGAGCGGG[TAM]
probeDNA-STM227 [6FAM]TCGCGGGAGATCGTGGTTTAGAGG[TAM]
probeDNA-STM232 [6FAM]ATGGCGTTGTCGATATGGTTAGGTA[TAM]
probeLNA-STM240* [6FAM]catccaccc+Cgatccaac[TAM]
*: For STM6, STM20, STM43, STM219 and STM240, Locked Nucleic Acid (LNA) were used as indicated (+) in the oligonucleotide sequence in order to reach a Tm suitable
for qPCR reactions.
doi:10.1371/journal.pone.0026962.t002
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oligomers in a pKS(+) backbone to avoid the problem of the non-
palindromic DraIII site. Finally 10 plasmids were generated from
the CIp30 backbone containing each a specific tag and were called
CIp30-STM6,211,220,243,2209,2219,2224,2227,2232
and 2240.
For the construction of the orf19.2646 revertant strains,
pAC249 was designed to re-introduce a wild-type orf19.2646
allele at its genomic locus. For this purpose, the SAT1 gene was
amplified from pSFS2 using the primers Sat1-Not (59-ATAA-
GAATGCGGCCGCGTCAAAACTAGAGAATAATAAAG-39)
and Sat1-BamHI (59-GCAAAGGATCCCACCACCTTT-
GATTGTAAAT-39). This fragment was introduced into pBlue-
script KS+ by BamHI and NotI to yield pDS1551. Next,
orf19.2646 was amplified using the primers orf19.2646-5-for (59-
CGCGAGGTACCTCAATCAAGCCTCCTGTACC-39) and orf-
19.2646-Rxho (59-CGCGACTCGAGTGTACACAAAACTTA-
GAACC-39). The resulting PCR fragment was cloned into
pDS1551 by KpnI and XhoI to yield pAC249.
Construction of orf19.2646 revertant and control strains
The plasmid pAC249 was introduced into the STM-tagged
orf19.2646 mutant strain (BCY152) by SpeI digestion allowing
integration at the orf19.2646 genomic locus. In parallel, the
parental plasmid pDS1551 was introduced into BCY152 and into
the tagged-BWP17 (BCY31) strains at the ACT1 locus by MunI
digestion.
Animal experiments and Ethics Statement
All animal experiment were performed at the University of
Lausanne and at the University hospital center under the
surveillance and with the approval of the institutional Animal
Use Committee: Affaires Ve´te´rinaires du Canton de Vaud,
Switzerland; with the authorization nu 1734.2 and 1734.3,
according to the decree 18 of the federal law on animal protection.
Strains were grown in individual tubes for 16 hours under
agitation at 30uC in YNB. Each strain was then diluted 100-fold
times in YEPD and grown overnight under agitation at 30uC.
Overnight cultures were washed twice in PBS and resuspended in
5 ml PBS. Concentration of each culture was measured and each
strain was diluted in PBS at a concentration of 26106 cells/ml. For
injection of the 10 strains pools, one ml of each diluted strain was
mixed. Aliquots of each single culture and of the mix were plated
onto YEDP in order to count colony-forming units (CFU).
Female BALB/c mice (20 to 25 g; Charles River France) were
housed in ventilated cages with free access to food and water. To
establish C. albicans infection, mice were injected into their lateral
tail vein with 250 ml of saline suspensions containing 56105 CFU
of C. albicans mixed strains. Groups of three mice were established
for each pool or single strain infection. Group of four to five mice
were used for orf19.2646 revertant experiments. Mice were
monitored daily and were sacrificed three days after infection by
CO2 inhalation. Kidneys were excised aseptically and weighted.
The two kidneys were homogenized together in 5 ml sterile water
and 100 ml of organ homogenates were used to count CFUs. The
remaining homogenates were centrifuged and pellets were frozen
overnight for further analyses. To analyse the CFU results, 10-fold
dilutions of kidney extracts were plated onto YEPD supplemented
with 50 mg/ml of chloramphenicol. Statistical significance of single
infections was determined with the Kruskal-Wallis test.
Preparation of C. albicans DNA from mice kidneys
Frozen pellets of kidneys homogenates were thawed slowly at
room temperature, resuspended in 2 ml of water and then
dispatched equally in 2 ml screw caps tubes. Tubes were
centrifuged for 1 min at maximum speed. One pellet was kept
for further analyses. The other pellets were washed three times in
lysis buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM
Tris HCl pH 8, 1 mM EDTA) in order to eliminate mice tissue
debris. Yeast cells were resuspended in 200 ml of lysis buffer
supplemented with one volume of phenol-chloroform. Cells were
next disrupted by adding one volume of glass beads and by
agitating the solution for 15 seconds at a power of 5 in a Fastprep
24 instrument (MP Biomedical, France). Suspensions were then
centrifuged for 10 min at maximum speed. The aqueous phase
was recovered and DNA was precipitated with 2 volumes of
absolute ethanol. Pellet was resuspended in 50 ml of TE (10 mM
Tris HCl pH 7.5, 1 mM EDTA) in which 10 ml of RNase A
(Roche) (10 mg/ml) was added. Solution was incubated for 30 min
at 37uC. Ten ml of proteinase K (Sigma) (10 mg/ml) were added
and solution was incubated for 30 min at 65uC. DNA was then
precipitated and resuspended in TE. After overnight incubation at
4uC, the concentration of DNA was measured using a Nanodrop
ND1000 equipment (ThermoScientific, DE, USA).
Quantitative real-time PCR (qPCR) and normalization
qPCR reactions were performed with 0.2 mM of each primer,
0.1 mM of probe and iTaq supermix with ROX (BioRad, Reinach,
Switzerland) according to the manufacturer’s instructions. Cycling
conditions were as following: 2 min at 50uC, 3 min at 95uC
followed by 40 cycles of 15 s at 95uC and 1 min at 60uC.
Amplification and detection of PCR products were performed with
a Step One PlusTM (Applied Biosystems, CA, USA). Reactions were
performed in a total volume of 25 ml. Data were analysed using the
Step One software V2.1 (Applied Biosystems, CA, USA). In each
run, a PCR control was performed with yeast DNA extract from
kidneys of non-infected mice. The signals obtained gave the noise
level of the qPCR. Each sample showing a CT for STM6 (wild type
strain) higher than that of the non-infected mice reaction was
rejected since C. albicans DNA extraction from kidneys probably
failed. Such samples were eliminated for further analysis. Standard
curves were created with 10-fold serial dilutions (105 to 101 copies)
of the ten CIp30-STM plasmids. These ten standard curves (one for
each barcode) were used to determine the copy number (Qx) of the
different barcodes carried by strains of each pool from infected mice
kidney (QxINVIVO) or from 24h YEPD cultures (QxINVITRO). To
determine an increase or decrease of growth of strains in vivo as
compared to in vitro conditions, the ‘‘in vivo/in vitro’’ ratio (dQx=
QxINVIVO/QxINVITRO) was calculated for each STM barcoded
strain. This dQx ratio calculation allows the normalization of the in
vivo data to the in vitro growth of each mutant strain. Finally, to
obtain the colonization score of each strain (S = log2 (dQx/
dQSTM6)), each dQx ratio was normalized to the dQSTM6 of its pool
in order to normalize the results of all pools. The STM6 barcode
was contained in isogenic wild type strains present in all the pools as
positive control.
Results
In order to discover new C. albicans virulence factors and to help
elucidating novel elements in host-pathogen interactions, we
propose here to screen a collection of C. albicans transcription
factor mutants in a murine disseminated infection model.
The murine disseminated infection model is a conventional
experimental model to study C. albicans pathogenicity. In this
model, several organs such as brain, spleen, lungs, liver and
kidneys are infected by C. albicans. We planned to use this model of
infection to evaluate organ colonization by Zn2-Cys6 TF mutant
strains. For this purpose, we used mutants from an already existing
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collection containing 239 mutants corresponding to almost all the
mutants of non-essential TF genes of C. albicans [40,41,42]. To
reduce the number of animals used in this study, the 77 Zn2-Cys6
TF mutant strains were tested by pools as described in Figure 1
and Table 1. We developed a strategy to tag strains of a pool with
40-mers barcodes enabling their specific and individual detection
(see Material and Methods and Figure 2). This original strategy of
screening limits the number of tags, primers and probes to detect
each strain in a pool and thus reduces considerably the costs of
screening.
In vitro detection of barcoded C. albicans strains
A pool of infection contained ten strains: eight strains of the TF
mutant collection, a wild type strain as a positive control and an
avirulent strain (a cmp1D mutant) as a negative control. Each strain
of the pool was tagged with a barcode consisting of a unique 40
oligonucleotides sequence (Table 2) selected among STM
(Sequence Tag Mutagenesis) tags previously used in C. neoformans
[38,39]. Each barcode was cloned in a C. albicans optimized
plasmid (CIp30) [37] and transformed in TF mutant strains as
indicated in Table 1. Ten sets of Taqman probes and primers were
designed as presented in Figure 2 for STM6 in order to specifically
detect each barcode.
Our first attempt was to specifically detect each barcode in vitro.
For this purpose, the ten STM-CIp30 plasmids were introduced
into the wild type strain BWP17. We thus obtained ten strains
differing only by their barcodes. Using DNA from in vitro culture of
each strain and from co-culture of all strains, we were able to
detect each strain specifically (data not shown). Our second
attempt was to determine the limit of detection of a strain within a
pool. The DNAs of the ten BWP17-tagged strains, except the one
carrying the STM11-tag, were mixed in an equal amount. The
DNA of the STM11-tagged strain was diluted to a concentration
of 10 ng/ml and 10-fold serially diluted to reach a concentration of
0.01 ng/ml. Each dilution was mixed with 10 ng of pool DNA.
STM11 was detected specifically in the different samples (Figure 3).
BWP17-STM11 DNA can be detected even if 500-fold diluted in
the pool as compared to other DNAs (Figure 3).
The set of ten barcoded plasmids, primers and probes designed
for their detection represents therefore a powerful tool optimized
for the in vitro qPCR detection of a given C. albicans tagged strain
within a mixed population.
Detection of C. albicans barcoded strains in vivo
The subsequent test was to assess the detection of each barcode
in vivo. We first determined the threshold above or under which a
strain may be considered as colonizing mice organs differently
than the wild type. For this purpose a ‘‘BWP17 in vivo pilot assay’’
was performed with a pool containing ten BWP17-tagged strains
as described above. This in vivo pilot assay was performed three
times with groups of three mice. At day three post-infection, which
is the minimal time for C. albicans required to complete a systemic
infection [43], mice kidneys were recovered. C. albicans DNA
extraction from mice kidneys was optimized [44] to reduce
contamination by mammalian DNA. In parallel, C. albicans DNA
was also extracted from a 24 h in vitro co-culture in 50 ml YEPD of
the same inoculum (250 ml). The relative abundances of each
DNA were quantified by qPCR. The detection of each barcode
from mice kidneys was successful. The score of infection of each
BWP17-tagged strain was calculated relative to that of the
BWP17-STM6 strain as described in Material and Methods.
When the results of the three independent experiments were
Figure 1. Flow chart describing the principal steps (A to E) of in vivo screening of the TF mutant collection. A: To enable the
simultaneous testing of several mutants in animals, strains are tagged with 40 nucleotides barcodes. B: Mice are infected with pools of 10 barcoded
strains. C: In parallel, pools are grown 24-hours in vitro. D: C. albicans DNA are extracted from mice kidneys and in vitro co-culture. E: Each barcoded
mutant of the pool is relatively quantified by real-time qPCR in DNA extracted from mice organs and in vitro co-cultures.
doi:10.1371/journal.pone.0026962.g001
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pooled, the medium score has a value of 20.05 (6 0.72)
(Supplementary File S1). This value, to which 6 two standard
deviations were added (1.39 to 21.49), corresponds to the
threshold above or under which a strain has a different
colonization potential as compared to the wild type.
Each pool contains a cmp1D strain as a negative control of
infection. CMP1 encodes for the catalytic subunit of calcineurin.
Previous studies extensively described that strains lacking a
functional calcineurin are avirulent and unable to colonize mice
organs in the model of disseminated infection [45,46,47]. To
validate our screening system, we verified whether or not such a
strain could be detected from infected mice tissues. For this
purpose, we performed a so called ‘‘CMP1‘‘ pilot experiment, in
which a pool containing a BWP17-STM6 tagged strain and nine
cmp1D strains carrying the other barcodes was injected in groups
of three mice. The cmp1D mutants (all tags combined) showed a
score of 24.02 (6 2.12) (data not shown), thus confirming that
the system was able to detect a strain with a colonization score
lower than the wild type. These in vivo pilot assays demonstrated
that our strategy of screening was functional in vivo and also
defined the limits of detection and interpretation of the
results.
Analysis of ten pools of Zn2-Cys6 TF mutant strains
The screening of the 77 C. albicans Zn2-Cys6 mutant strains in a
mouse model of systemic infection was performed by designing ten
pools of infection as detailed in Table 1. These 77 mutants
correspond to only 74 mutated genes since three genes were
mutated twice independently (i.e. orf19.5133, orf19.3012 and
orf19. 3876) (Supplementary File S1). All mutant strains were
transformed with plasmids derived from STMx-CIp30. These
plasmids carrying the STM-tags allow also to re-introduce URA3,
HIS1 or ARG4 markers in a neutral locus for virulence [37].
Pool 1 was containing nine strains with a CAF4-2 background
(Table 1 and Supplementary File S1). The seven Zn2-Cys6 TFs
and the cmp1D mutants of the pool were constructed using URA
STM11 + 20 ng others STM
STM11 alone
blank
200ng 20ng 2ng 0.2ng 0.02ng
Figure 3. Limit of detection of a given barcoded strain in a pool. Signal curves of qPCR over cycle numbers: samples contain 10 ng of the
DNA of nine barcoded strains equally mixed and 10-fold serial dilutions of the DNA (from 200 to 0.02 ng) of the strain with the barcode STM11
(Orange). Samples contain only 10-fold serial dilution of the DNA (from 200 to 0.02 ng) of the strain with the barcode STM11 (Blue). No template
control corresponds to the limit of DNA detection of the assay (Black).
doi:10.1371/journal.pone.0026962.g003
Figure 2. CIp30-STM6 detection. Details of the CIp30 plasmid sequence, in which the barcode (here STM6) was cloned between DraIII and NotI
restriction sites. The localization of the STM6 barcode (purple), the position where the Taqman probe specific for STM6 is hybridizing (red) and the
positions of forward (dark green) and reverse primers (light green) are indicated. Note that the reverse primer hybridizes at the 39-extremity of the
barcode and thus enhances the specificity of detection.
doi:10.1371/journal.pone.0026962.g002
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blaster cassettes in the CAF4-2 background [48,49,50]. Therefore,
CAF4-2 containing STM6-CIp30 was the positive control. The
negative control was DSY2101 (cmp1D) containing STM240-
CIp30 (Table 1). The nine other pools contained isolates with a
BWP17 background. Each pool except pools 2 and 6 contained
eight Zn2-Cys6 TF mutants (only seven for pools 2 and 6), BWP17
tagged with STM6 and DSY4343 (cmp1D) tagged with STM240.
Mutants of these pools were obtained using different strategies as
detailed in Supplementary File S1.
Our first analysis was performed on cmp1D strains. When
merging the scores of BCY82 (cmp1D in the BWP17 background)
from pools 2 to 10 and from the ‘‘CMP1 pool’’ as detailed above,
we obtained an average score of 23.83 (6 2.42). It is important to
note that in some experiments, no qPCR signals could be obtained
for BCY82, probably because the DNA of this strain was under
the limit of detection. This means that the DNA of this strain was
at least 500-fold more diluted as compared to other DNAs of the
pool that included mice DNA from kidneys. BCY13 (cmp1D
mutant in a CAF4-2 background) showed a score of -4.15 (6 2.44)
(Figure 4 and Supplementary File S1). Both scores obtained for the
cmp1D strains (BCY82 and BCY13) were under the threshold value
of 21.49 as mentioned above, thus confirming that these strains
are less colonizing mice tissues than the wild type independently of
the genetic background. After setting the detection limits of our in
vivo screening system, we determined the colonization scores of all
strains of the Zn2-Cys6 TF mutant collection in comparison to
their isogenic wild type strains. The scores of all strains are
presented in Figure 4 and detailed in Supplementary File S1. The
majority of the strains have a score within the interval delimited by
the ‘‘BWP17 pool’’ assay, indicating that their colonization scores
were not significantly different from the wild type strains. In
contrast, four strains (as referred to hyper-colonizers), i.e. BCY27,
BCY150, BCY160 and BCY162 showed scores of 2.36, 3.23, 2.42
and 3.18, respectively, and were above the ‘‘BWP17 pool’’ limit.
This suggests a higher colonization capacity than the wild type.
Next, eight strains (as referred to hypo-colonizers), i.e. BCY36,
BCY21, BCY164, BCY88, BCY112, BCY122, BCY148 and
BCY152 showed scores below the ‘‘BWP17 pool’’ limit (23.2,
Figure 4. Strain scores of mice kidney colonization. S scores are plotted for each tested mutant. The scores were defined as the values
obtained by the equation: S score = log2(dQx/dQSTM6), where Qx is the relative quantification of the different C. albicans DNA as compared to a
standard curve included in each qPCR reaction for a given barcode. A first normalization was performed to limit the ‘‘pool effect’’ on the strain growth
and the PCRs efficacy effect by the equation dQx = QxINVIVO/QxINVITRO with X corresponding to a given barcode. A second normalization was
performed based on the wild type strain in order to compare each pool with each other. Since the barcode STM6 was carried by the wild type strain
in each pool as positive control, the following equation was applied: dQx/DQSTM6. The cmp1D strains carried always the barcode STM240. Orf19.5133
was mutated in two independent strains. Strain BCY158 yielded no result since qPCR signals were under the detection threshold.
doi:10.1371/journal.pone.0026962.g004
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22.57, 22.34, 21.65, 23.49, 22.08, 22.11, and 22.08,
respectively). These data suggest that these strains are poor
colonizers as compared to the wild type.
The four hyper-colonizers strains correspond to mutations of
orf19.4166, orf19.6781, orf19.1685 and orf19.391. The orf19.4166
(ZCF21), orf19.6781 (ZFU2) and orf19.1685 (ZCF7) encode TFs
with yet unknown functions. Interestingly, orf19.391 (also called
UPC2) encodes a TF regulating genes of the ERG family involved in
sterol biosynthesis and therefore plasma membrane integrity. Upc2
was also reported to be involved in antifungal resistance due to
acquisition of gain-of-function mutations [51,52,53,54].
The eight hypo-colonizer strains correspond to mutations of
orf19.3405 (ZCF18), orf19.255 (ZCF1), orf19.5133 (ZCF29),
orf19.2747 (RGT1), orf19.7570 (UGA3), orf19.6182 (ZCF34),
orf19.3753 (SEF1) and orf19.2646 (ZCF13). Interestingly,
orf19.5133 encodes a TF with yet unknown function and is
deleted and interrupted in strains BCY164 (pool 3) and BCY158
(pool 10), respectively. BCY164 (orf19.5133) contained the tag
STM209 and showed a score of 22.34 (6 1.13). BCY158, tagged
with STM224, did not appear as hypo-colonizer since no signal
above the background was obtained by qPCR for this strain.
Five other genes including orf19.3405, orf19.255, orf19.6182,
UGA3 and orf19.2646 encode Zn2-Cys6 TF with yet unknown
function. These TFs have been analysed in large scale screening of
mutants or found as target genes in transcriptional microarray
analyses [22,24,42,55]. RGT1 encodes a transcriptional repressor
involved in the regulation of glucose transporter genes [56]. SEF1
encodes a TF involved in iron assimilation and survival in
stationary phase at 30uC [57,58].
Single strain infections
In order to validate our previous results and in order to
eliminate false positives due to pool effect in the infections, we
performed single strain infection with seven hypo-colonizers and
BCY31 (BWP17 tagged with STM6). As in the case of pools
experiments, groups of 3 mice were infected intravenously with
56105 cells of C. albicans mutant strains. Kidney colonization was
next analysed by counting C. albicans CFUs in kidneys at three days
post-infection as performed in the pool experiments. Results are
presented in Figure 5. We observed that fungal burdens of all
mutant strains were lower than the wild type. Nevertheless, only
mutants for orf19.3405 and orf19.2646 showed a significant
statistical difference in tissue colonization as compared to BCY31
(8.116103 and 1.096104 CFU/g kidney for mutants and
1.246107 for BCY31). Therefore, these two mutants constitute
interesting candidates for further analyses.
In vitro phenotypes of Zn2-Cys6 TF mutants
In an attempt to correlate in vivo results with putative functions
of identified TFs, the whole collection was screened for six
phenotypes potentially relevant for in vivo growth by comparing
each mutant with its parent wild type strain. First, we determined
resistance to heat and oxidative stress by incubation at 42uC and in
H2O2-supplemented medium, respectively, and growth capacities
at alkaline or acidic pH of each mutant on rich media.
Considering the environmental conditions that C. albicans faces
within the host, an enhanced or reduced resistance to heat-,
oxidative- or pH-stresses may give indications regarding the
involvement of a given Zn2-Cys6 TF in virulence and/or
colonization abilities. Since switching from the yeast to hyphal
form is known to be a determinant of virulence [59], the ability of
each mutant to produce true hyphae and/or pseudohyphae was
also assessed. For that purpose, colony wrinkling was visually
inspected after 72 h of incubation on rich media supplemented
with 10% serum, which is known to induce filamentation in C.
albicans [59]. Moreover, agar invasion was quantified by washing
YEPD agar plates after 48 h of incubation at 35uC and by visually
evaluating a decrease or an increase of invasive growth as
compared to the wild type strain. Raw pictures of this screening
are provided as supplementary data (see Supplementary Files S2,
S3, S4, S5, S6, S7). Lastly, pictures of cells grown for 4 h in YEPD
liquid media supplemented with 10% FCS were analyzed for the
presence of true hyphae.
Overall, 39 out of 74 mutants displayed an altered phenotype
regarding the six criteria tested here (Tables 3, Figure 6 and
Supplementary File S1, sheet ‘‘phenotype’’). Only a few mutants
displayed altered susceptibilities to heat, pH and H2O2. Indeed,
none of the mutants showed impaired growth at acidic pH and
only one of them, SEF1, exhibited decreased growth at alkaline
pH. Likewise, only one mutant, orf19.3188 (TAC1) was hypersus-
ceptible to H2O2. Two mutants had a decreased growth capacity
at 42uC, namely orf19.5849 (CWT1), and orf19.2646 (ZCF13).
The largest phenotypic alterations were observed in morphology-
discriminative conditions since among the 39 mutants displaying a
phenotype in our screen, 28 were selected for their abnormal
morphology on solid YEPD 10% FCS media and/or their altered
ability to invade agar (Figure 6 and Supplementary file S1, sheet
‘‘phenotype’’). Out of 22 mutants with abnormal morphology, 13
produced less wrinkled colonies as compared to their respective
wild-type parents and 9 an increased colony wrinkling. Regarding
agar invasion ability, 6 and 5 mutants showed increased and
decreased invasion in the solid substrate, respectively, as compared
to the wild-type (Figure 6 and Table 3).
Liquid YEPD 10% FCS media cultures allowed the selection of
21 mutants with a modified cell morphology as compared to their
parental wild type strains. Mutants with more than 80% of cells
forming hyphae were scored as positive. In contrast, mutants
showing less than 10% of hyphae were scored as negative (see
Table 3 and Supplementary file S1, sheet ‘‘Phenotype’’). Fol-
Figure 5. Single strain infections. Seven strains with the lowest
scores of colonization in the pool experiments were tested for kidney
colonization by single strain mice infection. Groups of three mice were
infected with a unique strain. Three days after infection, kidneys were
harvested and CFU were measured. Symbol (*) indicates a p-value #
0.05 by the Kruskal-Wallis test.
doi:10.1371/journal.pone.0026962.g005
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lowing these criteria, 11 mutants displayed almost no hyphae
formation. In contrast, 10 displayed an increase in true hyphae
formation.
In vivo single infection experiments allowed the selection of two
interesting TF (orf19.2646 and orf19.3405) mutant strains for their
hypo-colonizer phenotype in kidneys. Mutant for orf19.2646
Figure 6. Filamentation, invasive growth and susceptibility to heat, oxidative and pH stresses of the Zn2-Cys6 TF mutants. Pictures
of serial dilutions assay plates for the Zn2-Cys6 TF mutants displaying an in vitro phenotype (see Supplementary File S1 for phenotype details) were
taken after 24, 48 or 72 h of incubation. Mutants are referenced on the left side of each panel according to the disrupted ORF number (see
Supplementary File S1). Conditions of incubation are indicated on the top of the figure. (A) Reference panel attributing a score relative to wild type
phenotype (score 0), is given for better visualization of differences between BWP17-based mutants and wild type regarding (B) invasion and (C)
filamentation phenotypes. Since only one filamentation and one invasion altered phenotypes were observed for CAF4-2-based mutants (i.e mutant
for orf19.7374), such a reference panel was not included. (D) Growth of orf19.3188 (TAC1) mutant on H2O2-containing medium. (E) Mutants with
reduced growth at 42uC or (F) alkaline pH. The phenotypes of each mutant were compared with its respective parental strain, which was spotted on
each plate for reference.
doi:10.1371/journal.pone.0026962.g006
Table 3. ORFs deleted in the Zn2Cys6 TF mutants with altered phenotypes on solid media as compared to wild type strain.
Altered phenotype
Increased susceptibility to Agar invasion Colony wrinkling Hyphae formation
Heat
Oxidative
stress Alkaline pH Increased Decreased Increased Decreased Increased Decreased
orf19.2646 orf19.3188 orf19.3753 orf19.2623 orf19.2447 orf19.431 orf19.1255 orf19.1168 orf19.166
orf19.5849 orf19.2646 orf19.4649 orf19.1497 orf19.1685 orf19.3305 orf19.1685
orf19.3190 orf19.5251 orf19.1718 orf19.2280 orf19.3405 orf19.2647
orf19.5097 orf19.6985 orf19.2646 orf19.3190 orf19.4649 orf19.2747
orf19.5729 orf19.7374 orf19.2808 orf19.4998 orf19.4766 orf19.3188
orf19.5992 orf19.3127 orf19.5133 orf19.5097 orf19.3753
orf19.3308 orf19.5251 orf19.5729 orf19.3986
orf19.5097 orf19.5548 orf19.6038 orf19.4998
orf19.6781 orf19.6985 orf19.6985 orf19.5133
orf19.6888 orf19.7374 orf19.7381 orf19.5849
orf19.7381 orf19.7374
orf19.7583
doi:10.1371/journal.pone.0026962.t003
Mice Colonization by Zn2-Cys6 TF Mutants
PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e26962
produced highly wrinkled colonies on YEPD agar medium
supplemented with 10% FCS and also better invaded the agar
as compared to the wild-type. Mutant for orf19.3405 showed a
growth deficiency in all conditions tested (Figure 6) but displayed
an increased production of true hyphae in liquid YEPD
supplemented with 10% FCS (Table 3 and Supplementary file S1).
Reversion of the orf19.2646 deletion phenotypes
We further investigated orf19.2646 since it appeared as a
promising candidate to discover yet unknown virulence factors. To
confirm that both in vitro and in vivo phenotypes observed were
effectively due to the interruption of orf19.2646, we constructed a
revertant strain by re-introduction of a wild-type gene at the
genomic locus in the BCY152 background (see Materials and
Methods). As shown in Figure 7A, the revertant strain exhibited as
the parent wild-type no growth deficiency at 42uC and no longer
displayed a wrinkled colony morphology in contrast to the mutant
strain. Likewise, animal experiments confirmed that the re-
introduction of orf19.2646 restored a colonization capacity
comparable to the wild-type strain which was also statistically
different from the mutant (Figure 7B).
Discussion
In this work, we screened at large scale the role of C. albicans
Zn2-Cys6 TFs in organs colonization using a mouse model of
systemic infection. For this purpose, we developed a screening
strategy infecting mice with pools of ten strains tagged with a set of
ten barcodes consisting of 40-nucleotides sequences. Among the 77
Zn2-Cys6 TF mutants tested corresponding to 74 mutated ORF,
four resulted in a hyper-colonizer phenotype while eight showed
Figure 7. Phenotypes of orf19.2646 mutant and revertant strains. (A) In vitro growth in YEPD agar medium at either 35 or 42uC for 24 h.
Enhanced resolution picture was taken after 48 h of incubation at 35uC to better visualize the wrinkled colony phenotype. (B) In vivo colonization
assay. Groups of four to five mice were infected with either wild-type, orf19.2646 mutant or revertant strains. Three days after infection, kidneys were
harvested and CFU were measured. Symbol (*) and (**) indicate a p-value # 0.05 and 0.01, respectively, as determined by the Kruskal-Wallis test.
doi:10.1371/journal.pone.0026962.g007
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hypo-colonizer phenotype (see Supplementary file S1). Recently,
similar large-scale in vivo mutant screening were performed by
Noble et al. [24] and Chamilos et al. [55]. This last work was
performed in the Toll mutant fly model, and focused on 33 TF
mutants with no restriction on the TF class [55]. The mutants used
came from the same TF mutant collection as used here. Twelve
mutants were common between this study and ours (see
Supplementary file S1, ‘‘all-scores’’ sheet). Among these twelve
mutants, none were found hypo-colonizer in the fly model and
only one (UGA3) was found hypo-colonizer in our pool
experiment. The use of two distinct infection models might
explain the discrepancies between both studies.
The work of Noble et al. [24] was more similar to our analysis
since mutant strains of this study were barcoded and were infecting
mice as pools. Nevertheless, our analyses were different since
Noble et al. [24] did not target a specific class of genes and
developed their own strategy of screening associated to their
particular mutant collection [24]. Consequently, out of the 77
Zn2-Cys6 TF mutants tested here, only 26 were common with the
study of Noble et al. [24] (see Supplementary file S1, ‘‘all-scores’’
sheet). Three of the eight hypo-colonizers mutants, namely
mutants for orf19.255 (ZCF1), orf19.6182 (ZCF34) and SEF1,
were also tested in their study. Only the mutant for SEF1 showed a
hypo-colonizer phenotype in both studies (Table 4). Transcrip-
tional analyses on iron metabolism in C. albicans showed that SEF1
might be involved in iron uptake regulation [58]. Interestingly,
Chen et al. [60] demonstrated recently that SEF1, as observed here
(Table 4), is critical for in vivo colonization. The SEF1 deletion was
accompanied by a decreased virulence in the mice bloodstream
infection model [60]. Fortunately, none of the mutants found as
hypo-colonizers by Noble et al. [24] were missed using our strategy.
Besides, none of the four mutants that were found hyper-
colonizers were identified by Noble et al. [24]. To our knowledge,
the remaining four mutants found here as hypo-colonizer
including mutants for orf19.5133 (ZCF29), orf19.3405 (ZCF18),
orf19.2646 (ZCF13) and RGT1 have not yet been identified in
studies addressing virulence or organ colonization in animal
studies.
Table 4. In vitro phenotypes of C. albicans Zn2-Cys6 TF mutants with hypo- or hyper-colonization phenotype in a mice model of
disseminated candidiasis.
ORF number Gene name Phenotype in our study Other phenotypes
Hyper- colonizers
19.6781 ZFU2 increased colony wrinkling on serum decreased invasive growth [69]
weak enhancement of invasion of YEPD medium [22]
19.1685 ZCF7 decreased colony wrinkling on serum impaired growth on Lee’s medium [22]
no hyphae formation in liquid YEPD serum reduced colony wrinkling on Spider medium [22]
19.391 UPC2 no phenotype accumulation of abnormal sterol intermediates [53]
hypersusceptible to azole antifungals [53]
decreased anaerobic growth rate [70]
haploinsufficiency on SLAD medium [69]
19.4166 ZCF21 no phenotype weak resistance to Caffeine [22]
weak resistance to Copper at 37˚C [22]
marginal sensitivity to Calcofluor White [22]
Hypo- colonizers
19.3405 ZCF18 growth-deficient on YEPD media hypersusceptible to virgineone [71]
increased hyphae formation in liquid YEPD serum
19.255 ZCF1 no phenotype no phenotype
19.5133 ZCF29 decreased colony wrinkling on YEPDA serum strong sensitivity to Caffeine and Menadione [22]
no hyphae formation in liquid YEPD serum strong resistance to Fenpropimorph [22]
19.2747 RGT1 decreased invasive growth decreased resistance to 2-deoxy-D-glucose [67]
no hyphae formation in liquid YEPD serum increased filamentous growth [56,67]
strong reduction of colony wrinkling at 37˚C and 42˚C [22]
19.7570 UGA3 no phenotype no phenotype
19.6182 ZCF34 no phenotype increased susceptibility to clotrimazole [69]
increased mortality rate in stationary growth phase [57]
abnormal morphology on solid Spider medium [24]
19.3753 SEF1 hypersusceptibility to alkaline pH increased mortality rate in stationary growth phase [57]
no hyphae formation in liquid YEPD serum strong sensitivity to elevated pH, weak sensitivity to SDS [22]
haploinsufficiency on SLAD medium [69]
decreased colonization [24,60]
19.2646 ZCF13 increased colony wrinkling and invasion no phenotype
hypersusceptibility to heat
doi:10.1371/journal.pone.0026962.t004
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To further characterize the putative function of the Zn2-Cys6
TFs deleted in our study, we screened the whole collection for
altered hyphae formation and colony morphology on serum,
invasive growth and susceptibility to pH, heat and oxidative
stresses. These six phenotypic criteria are known to play a major
role in C. albicans pathogenesis (for review see [59]). SEF1 mutant
had an impaired growth at alkaline pH, which has already been
described by Lan et al. [58]. Only one mutant displayed altered
susceptibility to H2O2. Interestingly, this mutant was TAC1
(orf19.3188), the main regulator of the expression of genes
encoding transporters belonging to the ATP-binding cassette
family, which are known to mediate azole resistance [48]. Liu et al.
found that TAC1 is regulating some genes involved in oxidative
stress response such as GPX1 and SOD5 [61]. Moreover several
studies suggested that azole drugs are able to generate an oxidative
stress through mitochondrion metabolism disturbance [62,63,64].
Our observation further reinforces this hypothesis.
Lastly, only two mutants were hypersusceptible to heat stress,
namely mutants for orf19.5849 (CWT1) and orf19.2646 (ZCF13).
To our knowledge, and without any further investigations, no
obvious correlation between impaired growth at 42uC and the
putative functions of these TFs could be observed.
Contrary to pH, oxidative and heat stresses, most of the
phenotypes altered in our TF mutants were hyphae production in
liquid medium supplemented with serum, morphological aspect of
colonies, and invasive growth (Table 3, Figure 6 and Supplemen-
tary file S1). In C. albicans, several parameters are known to induce
hyphal formation (serum and temperature as example) however
the mechanisms by which this yeast can sense contact with a
surface and can promote invasion of soft substrates like agar
medium or host tissue are still not fully understood [65]. However,
invasive growth and colony wrinkling are two partially indepen-
dent mechanisms (or at least mechanisms mediated by different
effectors) helping C. albicans to cope with the requirements of its
environment. Our results further demonstrate that agar invasion,
colony wrinkling, and hyphae formation could not be correlated
since a high discrepancy was observed while performing in vitro
phenotypic screening of our TF mutants collection.
More than the hyphal form itself, the ability of C. albicans to
switch from yeast to hyphae or pseudohyphae is of crucial
importance for its virulence [66]. Accordingly, no correlation
between colony wrinkling and/or hyphae formation in liquid
medium and reduced organs colonization could be made from our
results (Figure 8). Indeed, only four of our hypo-colonizer mutants
(orf19.5133, orf19.2747, orf19.3753, and orf19.1685) have a
reduced hyphae production. Likewise, only one hypo-colonizer
mutant lost its capacity to invade agar (orf19.2747), and only two
(orf19.5133 and orf19.1685) displayed smooth colonies. Even
mutant for orf19.2646 and orf19.3405, although compromized in
organ colonization, produced highly wrinkled colonies on serum-
supplemented media and a larger amount of hyphae in the
presence of serum, respectively, as compared to the wild type
(Table 3). Likewise, no correlation between increased filamenta-
tion on serum and colonization ability could be evidenced since all
but one (orf19.6781) of the hyper-colonizer mutants produce
highly wrinkled colonies on serum-supplemented media (Figure 6
and Table 3). This enhanced ability to produce hyphae may
explain partially its higher ability to colonize mice tissues.
One unexpected observation was the poor correlation between
decreased invasive growth and hypo-colonizer phenotypes as only
two hypo-colonizer TF mutants (for RGT1 and CTA4) displayed a
decreased agar invasion (Figure 6 and Table 4). This result may
appear surprising since it is well established that invasion ability is
a crucial determinant for the capacity of C. albicans to colonize host
tissues [66]. RGT1 was previously extensively analysed in vitro for
its role in sugar transport and metabolism [56,67], thus the
decreased colonization ability of RGT1 mutant might not be only
linked to its decreased invasion capacity but probably to a
combination with sugar metabolism. The CTA4 mutant, which
also produced smooth colonies on serum-supplemented media and
no hyphae in liquid media, has been described with a decreased
virulence by Chiranand et al. [68]. Even if virulence and
colonization are two distinct mechanisms of pathogenesis, it would
be interesting to address whether this mutant also exhibits
decreased virulence in the mice model of disseminated infection.
In conclusion, the reduced or enhanced ability of most of the
identified mutants to colonize mice kidneys could be at least
partially explained by their in vitro phenotype (Table 4). However,
a systematic relationship between criteria investigated here and
colonization ability could be ruled out from our results. Indeed,
among the 39 TF mutants positively selected from our in vitro test,
only 7 had a modified colonization capacity in mice as compared
to their wild type strains (Figure 8). Moreover, five of these twelve
TF mutants did not have any in vitro phenotype, suggesting that
their increased or decreased colonization ability could be
attributed to alternative virulence traits.
Finally, to validate results obtained with hypo-colonizer
mutants, single strain infections were performed with the seven
hypo-colonizer mutants and the wild type strain. Even if all
mutants showed decreased colonization as compared to wild type,
only two mutants for orf19.2646 (ZCF13) and orf19.3405 (ZCF18)
showed significant reduction of colonization by CFU counting in
kidneys as compared to the wild type. Surprisingly, these two
strains did not show the lowest colonization scores in pool
experiments. This result can be explained by a ‘‘pool effect’’,
which might influence the colonization of each strain of the pool.
Competition between strains can modify the behavior of a strain in
mice organs as compared to single strain infection. Our in vitro
analysis showed that the mutant for orf19.3405 (ZCF18) is slightly
growth-deficient, and thus might contribute to its hypo-colonizer
phenotype. Regarding mutant for orf19.2646, we observed an
increased ability to filament and to invade the agar and a growth
deficiency at 42uC. The phenotypes observed in vitro and in vivo
were reverted by the re-introduction of a wild-type allele in the
mutant strain confirming that phenotypes observed were effec-
tively due to the orf19.2646 (ZCF13) mutation. Orf19.2646
(ZCF13) therefore represents a very interesting candidate for
further analyses. The further characterization of the function of
this TF in virulence and identification of its target genes may
constitute promising basis for the better understanding of host-
Figure 8. Venn diagram of C. albicans Zn2-Cys6 TF mutants with
an in vitro and/or an in vivo phenotype. The 49 mutants (grey
circle) with altered morphology and/or invasive growth, or altered
susceptibility to pH, oxidative and/or heat stresses as determined by in
vitro serial dilutions assay and liquid culture were compared to the 12
mutants with increased or decreased mice kidney colonization capacity
(black circle). The remaining 22 mutants (white rectangle) did not
have either in vivo or in vitro phenotypes.
doi:10.1371/journal.pone.0026962.g008
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Candida interactions. In addition, analysis of the remaining mutants
of our collection may reveal other interesting candidates for
involvement in colonization and virulence.
Overall, our study demonstrates that our original strategy is a
powerful tool to detect both in vivo and in vitro competitive fitness.
This last in vitro approach is currently used in our laboratory.
Moreover, this detection system is easy to implement, could be
adapted to any pre-existing mutants and its efficacy could be
enhanced by the use of additional STM tags.
Supporting Information
Supplementary S1 This file contains five sheets. The ‘‘Zn2Cys6
TF’’ sheet describes the mutant collection and provides for each
mutant ORF number, gene name (when available) and description
according to the Candida Genome Database assembly #21. It also
provides information for inactivation strategy and numbering of
barcoded strains (BCY). The ‘‘Phenotype’’ sheet describes the
phenotype that was observed in vitro and a summary of the already
described phenotypes for each mutant. The ‘‘All scores’’ sheet
gives scores obtained for each replicate of in vivo experiments as
well as the mean score for each mutant (see also Figure 4). It also
gives information regarding previous large scale in vivo studies. The
‘‘BWP17 pilot assay’’ gives scores obtained for each replicate of the
first in vivo pilot assay performed with the 10 BWP17 barcoded
strains. Results are presented by STM. The ‘‘Supplementary
references’’ sheet lists the references used in the ‘‘Phenotype’’
sheet.
(XLSX)
Supplementary S2 Raw pictures of first in vitro phenotypic
screen plates after 24 h of incubation. Each TF mutant is
referenced according to its barcoded strain number (see Supple-
mentary_S1.xlsx), and has to be compared with its respective
parental strain (barcoded strain number 11 for CAF4-2 based TF
mutants and barcoded strain number 31 for BWP17 based TF
mutants) which was spotted on each plate for reference. Note that
susceptibility to H2O2 was only determined at 5 mM.
(EPS)
Supplementary S3 Raw pictures of first in vitro phenotypic
screen plates after 48 h of incubation. Each TF mutant is
referenced according to its barcoded strain number (see Supple-
mentary_S1.xlsx), and has to be compared with its respective
parental strain (barcoded strain number 11 for CAF4-2 based TF
mutants and barcoded strain number 31 for BWP17 based TF
mutants) which was spotted on each plate for reference.
(EPS)
Supplementary S4 Raw pictures of second in vitro phenotypic
screen plates after 24 h of incubation. Each TF mutant is
referenced according to its barcoded strain number (see Supple-
mentary_S1.xlsx), and has to be compared with its respective
parental strain (barcoded strain number 11 for CAF4-2 based TF
mutants and barcoded strain number 31 for BWP17 based TF
mutants) which was spotted on each plate for reference. H2O2
concentration was adjusted and susceptibility of TF mutants was
determined at 1 and 5 mM.
(EPS)
Supplementary S5 Raw pictures of second in vitro phenotypic
screen plates after 48 h of incubation. Each TF mutant is
referenced according to its barcoded strain number (see Supple-
mentary_S1.xlsx), and has to be compared with its respective
parental strain (barcoded strain number 11 for CAF4-2 based TF
mutants and barcoded strain number 31 for BWP17 based TF
mutants) which was spotted on each plate for reference.
(EPS)
Supplementary S6 Raw pictures of additional in vitro pheno-
typic screen performed for morphology determination. Each TF
mutant is referenced according to its barcoded strain number (see
Supplementary_S1.xlsx), and has to be compared with its
respective parental strain (barcoded strain number 11 for CAF4-
2 based TF mutants and barcoded strain number 31 for BWP17
based TF mutants) which was spotted on each plate for reference.
This was performed on YEPD agar plates supplemented with 10%
of serum after 24 and 72 h of incubation at 35uC.
(EPS)
Supplementary S7 Raw pictures of in vitro phenotypic screen
for TF mutants carrying the barcoded strain numbers BCY48,
BCY122, BCY124, BCY126, BCY166 and BCY164. These
strains were obtained in a second time during the course of this
study and therefore assayed independently from the main screen.
Each TF mutant is referenced according to its barcoded strain
number (see Supplementary_S1.xlsx), and has to be compared
with the parental strain (barcoded strain number 31) which was
spotted on each plate for reference.
(EPS)
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